Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC

May 15, 2026 7:09 AM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This amendment is filed to reflect the change in our percentage of ownership of Crinetics Pharmaceuticals, Inc. (CRNX). DCM owned 6.11% of CRNX as of March 31, 2026, down from 7.54% as of December 31, 2023.


SCHEDULE 13G



DRIEHAUS CAPITAL MANAGEMENT LLC
Signature:Janet McWilliams
Name/Title:General Counsel
Date:05/15/2026

Categories

SEC Filings